TickerFactsScreenerDevelopers

Enliven Therapeutics, Inc. (ELVN) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2019: -$21.88M2020: -$37.40M2021: -$46.77M2022: -$32.08M2023: -$61.27M2024: -$73.19M2025: -$70.30M-$70.30M
2019Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$70.30M+3.9%
2024-$73.19M-19.5%
2023-$61.27M-91.0%
2022-$32.08M+31.4%
2021-$46.77M-25.1%
2020-$37.40M-70.9%
2019-$21.88M—